UNITED THERAPEUTICS Corp (UTHR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 300M 600M 900M Q1 '09: 79.7M Q2 '09: 84M Q3 '09: 97.2M Q4 '09: 98M Q1 '10: 128.9M Q2 '10: 134.7M Q3 '10: 168.6M Q4 '10: 163.7M Q1 '11: 162.5M Q2 '11: 183.8M Q3 '11: 201.7M Q4 '11: 195.2M Q1 '12: 204.2M Q2 '12: 225.6M Q3 '12: 242.5M Q4 '12: 243.8M Q1 '13: 245.1M Q2 '13: 280.6M Q3 '13: 302.2M Q4 '13: 289M Q1 '14: 289.4M Q2 '14: 322.8M Q3 '14: 329.9M Q4 '14: 346.4M Q1 '15: 327.5M Q2 '15: 347.2M Q3 '15: 386.2M Q4 '15: 404.9M Q1 '16: 369M Q2 '16: 412.6M Q3 '16: 408.2M Q4 '16: 409M Q1 '17: 370.5M Q2 '17: 444.6M Q3 '17: 445.5M Q4 '17: 464.7M Q1 '18: 389.2M Q2 '18: 444.5M Q3 '18: 412.7M Q4 '18: 381.4M Q1 '19: 362.6M Q2 '19: 373.6M Q3 '19: 401.5M Q4 '19: 311.1M Q1 '20: 356.3M Q2 '20: 362M Q3 '20: 380.1M Q4 '20: 384.9M Q1 '21: 379.1M Q2 '21: 446.5M Q3 '21: 444.7M Q4 '21: 415.2M Q1 '22: 461.9M Q2 '22: 466.9M Q3 '22: 516M Q4 '22: 491.5M Q1 '23: 506.9M Q2 '23: 596.5M Q3 '23: 609.4M Q4 '23: 614.7M Q1 '24: 677.7M Q2 '24: 714.9M Q3 '24: 748.9M Q4 '24: 735.9M Q1 '25: 794.4M Q2 '25: 798.6M Q3 '25: 799.5M Q4 '25: 790.2M Q1 '26: 781.5M Q2 '26: 783.3M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

0 250M 500M 750M Q1 '10: 111.9M Q2 '10: 119.2M Q3 '10: 148.1M Q4 '10: 144.9M Q1 '11: 142.5M Q2 '11: 162.4M Q3 '11: 178.3M Q4 '11: 169M Q1 '12: 178.9M Q2 '12: 192.2M Q3 '12: 212.9M Q4 '12: 202.8M Q1 '13: 213.8M Q2 '13: 245.2M Q3 '13: 269.3M Q4 '13: 247.5M Q1 '14: 254M Q2 '14: 282.6M Q3 '14: 287.5M Q4 '14: 330.6M Q1 '15: 305.6M Q2 '15: 331.2M Q3 '15: 379.3M Q4 '15: 379.6M Q1 '16: 368.3M Q2 '16: 392.6M Q3 '16: 384.6M Q4 '16: 380.6M Q1 '17: 356.2M Q2 '17: 425.7M Q3 '17: 426M Q4 '17: 411.7M Q1 '18: 336M Q2 '18: 382.8M Q3 '18: 360.8M Q4 '18: 349.5M Q1 '19: 333.5M Q2 '19: 346.9M Q3 '19: 368.5M Q4 '19: 282.3M Q1 '21: 356.1M Q2 '21: 409.3M Q3 '21: 417M Q4 '21: 380.6M Q1 '22: 436M Q2 '22: 437.2M Q3 '22: 478.8M Q4 '22: 432.7M Q1 '23: 454.6M Q2 '23: 532.4M Q3 '23: 539.3M Q4 '23: 543.7M Q1 '24: 604.8M Q2 '24: 637.1M Q3 '24: 665.8M Q4 '24: 660M Q1 '25: 701.9M Q2 '25: 711M Q3 '25: 698.6M Q4 '25: 686.8M Q1 '26: 648.1M Q2 '26: 683.8M Q2 '11 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '22 Q2 '24 Q2 '26

Operating Income Quarterly

-750M -500M -250M 0 250M 500M 750M Q2 '09: -4.1M Q3 '09: 11.7M Q1 '10: 32.2M Q2 '10: 61.2M Q3 '10: 62.5M Q4 '10: 15.3M Q1 '11: 36.8M Q2 '11: 114.5M Q3 '11: 103M Q4 '11: 63.5M Q1 '12: 106.7M Q2 '12: 105.6M Q3 '12: 80.7M Q4 '12: 128.6M Q1 '13: 94M Q2 '13: 122.3M Q3 '13: 104.6M Q1 '14: 216.1M Q2 '14: 176.3M Q3 '14: -32.2M Q4 '14: 178.6M Q1 '15: -14.8M Q2 '15: 171.8M Q3 '15: 387M Q4 '15: 155M Q1 '16: 363.7M Q2 '16: 285.2M Q3 '16: 238.6M Q4 '16: 174.2M Q1 '17: 263.6M Q2 '17: 88.5M Q3 '17: 323.8M Q4 '17: 139M Q1 '18: 306.9M Q2 '18: 217.4M Q3 '18: 149.6M Q4 '18: 131.5M Q1 '19: -655.9M Q2 '19: 221.4M Q3 '19: 183.4M Q4 '19: 63.5M Q1 '20: 166.7M Q2 '20: 140.5M Q3 '20: 221.1M Q4 '20: 65.3M Q1 '21: -64.8M Q2 '21: 222.2M Q3 '21: 228.7M Q4 '21: 169.8M Q1 '22: 288M Q2 '22: 201.8M Q3 '22: 314.3M Q4 '22: 175.6M Q1 '23: 284.4M Q2 '23: 313.4M Q3 '23: 327M Q4 '23: 260.1M Q1 '24: 356.3M Q2 '24: 319.9M Q3 '24: 343.1M Q4 '24: 357.7M Q1 '25: 382.8M Q2 '25: 364.5M Q3 '25: 388.5M Q4 '25: 356.7M Q1 '26: 325.8M Q2 '26: 330.8M Q2 '10 Q3 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-600M -400M -200M 0 200M 400M 600M Q2 '09: -2.3M Q3 '09: 11.9M Q1 '10: 18.9M Q2 '10: 37.7M Q3 '10: 39.7M Q4 '10: 9.5M Q1 '11: 16.4M Q2 '11: 73.9M Q3 '11: 84.4M Q4 '11: 43.2M Q1 '12: 70.8M Q2 '12: 72.3M Q3 '12: 78.1M Q4 '12: 83.3M Q1 '13: 62.3M Q2 '13: 79.9M Q3 '13: 62.7M Q4 '13: -30.3M Q1 '14: 137.5M Q2 '14: 111.9M Q3 '14: -25.2M Q4 '14: 115.9M Q1 '15: -16.6M Q2 '15: 99.2M Q3 '15: 464.4M Q4 '15: 104.6M Q1 '16: 235.5M Q2 '16: 206.1M Q3 '16: 161.8M Q4 '16: 110.3M Q1 '17: 178.6M Q2 '17: -56M Q3 '17: 276.3M Q4 '17: 19M Q1 '18: 244.5M Q2 '18: 172.9M Q3 '18: 106.5M Q4 '18: 65.3M Q1 '19: -494.6M Q2 '19: 205.1M Q3 '19: 132.4M Q4 '19: 52.6M Q1 '20: 137.7M Q2 '20: 107.1M Q3 '20: 171.2M Q4 '20: 98.8M Q1 '21: 28.3M Q2 '21: 172.6M Q3 '21: 162.7M Q4 '21: 112.2M Q1 '22: 239.9M Q2 '22: 116M Q3 '22: 239.3M Q4 '22: 132.1M Q1 '23: 240.9M Q2 '23: 259.2M Q3 '23: 267.6M Q4 '23: 217.1M Q1 '24: 306.6M Q2 '24: 278.1M Q3 '24: 309.1M Q4 '24: 301.3M Q1 '25: 322.2M Q2 '25: 309.5M Q3 '25: 338.7M Q4 '25: 364.3M Q1 '26: 274.9M Q2 '26: 333M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 50M 100M 150M Q1 '17: 14.3M Q2 '17: 18.9M Q3 '17: 19.5M Q4 '17: 53M Q1 '18: 53.2M Q2 '18: 61.7M Q3 '18: 51.9M Q4 '18: 31.9M Q1 '19: 29.1M Q2 '19: 26.7M Q3 '19: 33M Q4 '19: 28.8M Q1 '20: 23.4M Q2 '20: 25.9M Q3 '20: 24M Q4 '20: 34.8M Q1 '21: 23M Q2 '21: 37.2M Q3 '21: 27.7M Q4 '21: 34.6M Q1 '22: 25.9M Q2 '22: 29.7M Q3 '22: 37.2M Q4 '22: 58.8M Q1 '23: 52.3M Q2 '23: 64.1M Q3 '23: 70.1M Q4 '23: 71M Q1 '24: 72.9M Q2 '24: 77.8M Q3 '24: 83.1M Q4 '24: 75.9M Q1 '25: 92.5M Q2 '25: 87.6M Q3 '25: 100.9M Q4 '25: 103.4M Q1 '26: 133.4M Q2 '26: 99.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-750M -500M -250M 0 250M 500M 750M Q3 '09: 16M Q4 '09: 26.3M Q1 '10: 34.2M Q2 '10: 35.2M Q3 '10: 102.8M Q4 '10: 39.3M Q1 '11: 53.4M Q2 '11: 64.5M Q3 '11: 80.7M Q4 '11: 51.6M Q1 '12: 37.6M Q2 '12: 87.4M Q3 '12: 93.4M Q4 '12: 105.2M Q1 '13: 97.7M Q2 '13: 83.8M Q3 '13: 139.3M Q4 '13: 104.4M Q1 '14: 110.6M Q2 '14: -54.5M Q3 '14: 208.5M Q4 '14: 90.6M Q1 '15: 109.1M Q2 '15: 41M Q3 '15: 207.2M Q4 '15: 25.5M Q1 '16: 125.8M Q2 '16: 125.7M Q3 '16: 228.7M Q4 '16: 163.4M Q1 '17: 230.8M Q2 '17: 70.7M Q3 '17: 258.5M Q1 '18: 275.7M Q2 '18: 179.8M Q3 '18: 237.5M Q4 '18: 85.4M Q1 '19: -627.4M Q2 '19: 132.9M Q3 '19: 185.4M Q4 '19: 102.5M Q1 '20: 214.6M Q2 '20: 164M Q3 '20: 250.9M Q4 '20: 126.2M Q1 '21: 89.8M Q2 '21: 148.2M Q3 '21: 185.6M Q4 '21: 174.6M Q1 '22: 288.7M Q2 '22: 127M Q3 '22: 258.6M Q4 '22: 128.2M Q1 '23: 374.8M Q2 '23: 106.3M Q3 '23: 346.2M Q4 '23: 150.7M Q1 '24: 376.5M Q2 '24: 232.2M Q3 '24: 377.2M Q4 '24: 341.2M Q1 '25: 461.2M Q2 '25: 191.7M Q3 '25: 562.1M Q4 '25: 346.2M Q1 '26: 463.3M Q2 '26: 313.6M Q2 '10 Q3 '12 Q4 '14 Q1 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Free Cash Flow Quarterly

-750M -500M -250M 0 250M 500M 750M Q3 '09: -8.1M Q4 '09: 4.8M Q1 '10: 27.9M Q2 '10: 32.5M Q3 '10: 98.7M Q4 '10: 33.8M Q1 '11: 47M Q2 '11: 52M Q3 '11: 62.8M Q4 '11: 50.9M Q1 '12: -2.7M Q2 '12: 43.7M Q3 '12: 86.7M Q4 '12: 84M Q1 '13: 93.5M Q2 '13: 79M Q3 '13: 129.9M Q4 '13: 91M Q1 '14: 91.9M Q2 '14: -67.3M Q3 '14: 194.9M Q4 '14: 88.4M Q1 '15: 105.1M Q2 '15: 37.2M Q3 '15: 196.7M Q4 '15: -6M Q1 '16: 122M Q2 '16: 115.3M Q3 '16: 219.6M Q4 '16: 148.7M Q1 '17: 215.2M Q2 '17: 49.8M Q3 '17: 236.5M Q1 '18: 238.1M Q2 '18: 126.3M Q3 '18: 196M Q4 '18: 33.6M Q1 '19: -652.5M Q2 '19: 112.6M Q3 '19: 171.8M Q4 '19: 77.8M Q1 '20: 201.6M Q2 '20: 145.8M Q3 '20: 235.1M Q4 '20: 113.9M Q1 '21: 79.2M Q2 '21: 131.9M Q3 '21: 162.3M Q4 '21: 104M Q1 '22: 275.2M Q2 '22: 110M Q3 '22: 189.8M Q4 '22: 88.7M Q1 '23: 333.5M Q2 '23: 61.6M Q3 '23: 280.5M Q4 '23: 72M Q1 '24: 338.3M Q2 '24: 187.1M Q3 '24: 300.7M Q4 '24: 254.5M Q1 '25: 386.3M Q2 '25: 129.5M Q3 '25: 351.6M Q4 '25: 173.3M Q1 '26: 362.5M Q2 '26: 205.6M Q2 '10 Q3 '12 Q4 '14 Q1 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '09: 53M Q3 '09: 57.7M Q1 '10: 60M Q2 '10: 60.4M Q3 '10: 60.2M Q1 '11: 62.6M Q2 '11: 62.8M Q3 '11: 61.2M Q1 '12: 55M Q2 '12: 53.9M Q3 '12: 53.6M Q1 '13: 52.4M Q2 '13: 52.6M Q3 '13: 53.7M Q1 '14: 56.7M Q2 '14: 53.3M Q3 '14: 47.3M Q1 '15: 46.7M Q2 '15: 51.9M Q3 '15: 50.2M Q1 '16: 48.7M Q2 '16: 46.9M Q3 '16: 46.2M Q1 '17: 45.9M Q2 '17: 44.9M Q3 '17: 44.1M Q1 '18: 43.9M Q2 '18: 43.4M Q3 '18: 44M Q1 '19: 43.7M Q2 '19: 44M Q3 '19: 44M Q1 '20: 44.1M Q2 '20: 44.4M Q3 '20: 44.6M Q1 '21: 46.4M Q2 '21: 47.3M Q3 '21: 47.6M Q1 '22: 47.7M Q2 '22: 48.1M Q3 '22: 48.7M Q1 '23: 49.6M Q2 '23: 49.5M Q3 '23: 49.7M Q1 '24: 49.7M Q2 '24: 47.5M Q3 '24: 48.4M Q1 '25: 48.6M Q2 '25: 48.3M Q3 '25: 47.3M Q1 '26: 47.2M Q2 '26: 45.8M Q1 '10 Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.00 0.00 10.00 20.00 30.00 Q4 '10: 1.75 Q1 '11: 1.69 Q2 '11: 2.25 Q3 '11: 2.97 Q4 '11: 3.59 Q1 '12: 4.62 Q2 '12: 4.78 Q3 '12: 4.86 Q4 '12: 5.69 Q1 '13: 5.59 Q2 '13: 5.77 Q3 '13: 5.48 Q4 '13: 3.28 Q1 '14: 4.52 Q2 '14: 5.10 Q3 '14: 3.40 Q4 '14: 6.17 Q1 '15: 3.38 Q2 '15: 3.19 Q3 '15: 12.96 Q4 '15: 12.89 Q1 '16: 18.09 Q2 '16: 20.57 Q3 '16: 14.83 Q4 '16: 15.16 Q1 '17: 14.21 Q2 '17: 8.57 Q3 '17: 11.34 Q4 '17: 9.34 Q1 '18: 11.02 Q2 '18: 16.25 Q3 '18: 12.40 Q4 '18: 13.45 Q1 '19: -3.44 Q2 '19: -2.76 Q3 '19: -2.17 Q4 '19: -2.45 Q1 '20: 11.99 Q2 '20: 9.74 Q3 '20: 10.57 Q4 '20: 11.54 Q1 '21: 9.03 Q2 '21: 10.27 Q3 '21: 9.85 Q4 '21: 10.02 Q1 '22: 14.44 Q2 '22: 13.20 Q3 '22: 14.69 Q4 '22: 15.00 Q1 '23: 14.83 Q2 '23: 17.66 Q3 '23: 18.13 Q4 '23: 19.81 Q1 '24: 21.12 Q2 '24: 21.73 Q3 '24: 22.74 Q4 '24: 24.62 Q1 '25: 25.08 Q2 '25: 25.64 Q3 '25: 26.41 Q4 '25: 27.89 Q1 '26: 27.08 Q2 '26: 27.94 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.